-
-
-
-
-
-
-
Eiger BioPharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Eiger Announces Peginterferon Lambda - Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress™ 2020
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

